<?xml version="1.0" encoding="UTF-8"?>
<p id="Par22">The exclusion criteria are as follows: 
 <list list-type="order">
  <list-item>
   <p id="Par23">Patients with lesions for which preferred early resection is preferred.</p>
  </list-item>
  <list-item>
   <p id="Par24">History of regular use (defined as at least once per week) of NSAIDs and/or aspirin.</p>
  </list-item>
  <list-item>
   <p id="Par25">History of regular use of warfarin and/or direct oral anticoagulants (DOAC).</p>
  </list-item>
  <list-item>
   <p id="Par26">History of diabetes mellitus (defined as a glycosylated hemoglobin (HbA1c) level more than 6.5% or regular use of anti-diabetic drugs).</p>
  </list-item>
  <list-item>
   <p id="Par27">History of heart failure, renal failure, liver cirrhosis or chronic hepatic failure.</p>
  </list-item>
  <list-item>
   <p id="Par28">History of familial adenomatous polyposis, hereditary non-polyposis CRC and inflammatory bowel disease.</p>
  </list-item>
  <list-item>
   <p id="Par29">Pregnancy or possibility of pregnancy.</p>
  </list-item>
  <list-item>
   <p id="Par30">Contraindication to aspirin or metformin.</p>
  </list-item>
  <list-item>
   <p id="Par31">Allergy to aspirin or metformin</p>
  </list-item>
  <list-item>
   <p id="Par32">Patients judged as inappropriate candidates for the trial by the investigators.</p>
  </list-item>
 </list>
</p>
